Pulse Biosciences (PLSE) Competitors $18.49 +1.09 (+6.26%) (As of 12:52 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends PLSE vs. PRCT, AXNX, NVCR, NVST, NARI, IRTC, LIVN, ENOV, WRBY, and CNMDShould you be buying Pulse Biosciences stock or one of its competitors? The main competitors of Pulse Biosciences include PROCEPT BioRobotics (PRCT), Axonics (AXNX), NovoCure (NVCR), Envista (NVST), Inari Medical (NARI), iRhythm Technologies (IRTC), LivaNova (LIVN), Enovis (ENOV), Warby Parker (WRBY), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. Pulse Biosciences vs. PROCEPT BioRobotics Axonics NovoCure Envista Inari Medical iRhythm Technologies LivaNova Enovis Warby Parker CONMED Pulse Biosciences (NASDAQ:PLSE) and PROCEPT BioRobotics (NASDAQ:PRCT) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, community ranking, dividends, valuation, institutional ownership and earnings. Do analysts rate PLSE or PRCT? PROCEPT BioRobotics has a consensus target price of $97.86, indicating a potential upside of 17.77%. Given PROCEPT BioRobotics' stronger consensus rating and higher probable upside, analysts plainly believe PROCEPT BioRobotics is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00PROCEPT BioRobotics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Which has higher valuation and earnings, PLSE or PRCT? Pulse Biosciences has higher earnings, but lower revenue than PROCEPT BioRobotics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulse Biosciences$700K1,618.78-$42.21MN/AN/APROCEPT BioRobotics$199.84M21.70-$105.90M-$1.95-42.61 Which has more volatility & risk, PLSE or PRCT? Pulse Biosciences has a beta of 1.78, meaning that its share price is 78% more volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Does the media refer more to PLSE or PRCT? In the previous week, Pulse Biosciences had 15 more articles in the media than PROCEPT BioRobotics. MarketBeat recorded 16 mentions for Pulse Biosciences and 1 mentions for PROCEPT BioRobotics. PROCEPT BioRobotics' average media sentiment score of 1.70 beat Pulse Biosciences' score of 0.75 indicating that PROCEPT BioRobotics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 6 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PROCEPT BioRobotics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do institutionals and insiders believe in PLSE or PRCT? 76.9% of Pulse Biosciences shares are held by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 71.5% of Pulse Biosciences shares are held by insiders. Comparatively, 17.4% of PROCEPT BioRobotics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community favor PLSE or PRCT? Pulse Biosciences received 209 more outperform votes than PROCEPT BioRobotics when rated by MarketBeat users. However, 67.86% of users gave PROCEPT BioRobotics an outperform vote while only 63.82% of users gave Pulse Biosciences an outperform vote. CompanyUnderperformOutperformPulse BiosciencesOutperform Votes24763.82% Underperform Votes14036.18% PROCEPT BioRoboticsOutperform Votes3867.86% Underperform Votes1832.14% Is PLSE or PRCT more profitable? Pulse Biosciences has a net margin of 0.00% compared to PROCEPT BioRobotics' net margin of -50.07%. PROCEPT BioRobotics' return on equity of -38.57% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Pulse BiosciencesN/A -96.89% -74.83% PROCEPT BioRobotics -50.07%-38.57%-26.06% SummaryPROCEPT BioRobotics beats Pulse Biosciences on 9 of the 16 factors compared between the two stocks. Ad Prosper Trading AcademyA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading system finds high-probability option trades in less than 60 seconds a dayClick HERE to access this powerful AI Trading System Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLSE vs. The Competition Export to ExcelMetricPulse BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.13B$4.35B$5.21B$9.23BDividend YieldN/A44.59%5.12%4.30%P/E RatioN/A24.9587.6917.23Price / Sales1,618.7853.121,166.33121.51Price / CashN/A43.4043.2337.84Price / Book22.747.114.814.92Net Income-$42.21M$13.64M$120.46M$225.43M7 Day Performance-4.26%0.12%-0.85%0.61%1 Month Performance4.19%-0.80%15.42%2.23%1 Year Performance45.50%39.35%29.98%16.55% Pulse Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLSEPulse Biosciences1.8258 of 5 stars$18.49+6.3%N/A+37.4%$1.14B$700,000.000.00140Analyst UpgradePositive NewsGap UpPRCTPROCEPT BioRobotics2.853 of 5 stars$89.72+0.5%$97.86+9.1%+92.9%$4.68B$136.19M0.00626Positive NewsAXNXAxonics1.4367 of 5 stars$70.98+0.8%$71.00+0.0%+13.5%$3.63B$366.38M-591.45610High Trading VolumeNVCRNovoCure2.187 of 5 stars$33.02-1.2%$32.67-1.1%+129.2%$3.57B$577.74M-23.861,453NVSTEnvista3.5083 of 5 stars$19.57+0.5%$20.65+5.5%-22.3%$3.37B$2.50B-2.5112,800NARIInari Medical3.3326 of 5 stars$56.26+1.2%$58.89+4.7%-19.0%$3.29B$574.50M-41.181,300IRTCiRhythm Technologies2.9446 of 5 stars$89.17+3.2%$107.82+20.9%-17.2%$2.79B$492.68M-17.782,000LIVNLivaNova3.4854 of 5 stars$50.06-2.8%$69.17+38.2%-9.3%$2.72B$1.24B122.622,900ENOVEnovis3.0152 of 5 stars$46.57+0.9%$67.00+43.9%-24.3%$2.60B$2.00B-21.396,550Positive NewsWRBYWarby Parker1.5906 of 5 stars$24.40+3.3%$20.73-15.1%+85.4%$2.48B$669.77M-87.523,491CNMDCONMED4.6326 of 5 stars$71.95-0.8%$79.80+10.9%-38.7%$2.22B$1.29B17.234,000Positive News Related Companies and Tools Related Companies PRCT Competitors AXNX Competitors NVCR Competitors NVST Competitors NARI Competitors IRTC Competitors LIVN Competitors ENOV Competitors WRBY Competitors CNMD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PLSE) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredTiny Mineral, Massive Market OpportunityImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLSE Stock Alerts